Results 61 to 70 of about 51,158 (208)
Purpose: Radical concurrent chemoradiotherapy with combined external beam radiotherapy (EBRT) and brachytherapy is used to treat locally advanced cervical cancer. Our institution has transitioned to high-dose-rate (HDR) intracavitary brachytherapy (ICBT)
Jiheon Song, MD, MSc +5 more
doaj +1 more source
Dosimetric equivalence of nonstandard HDR brachytherapy catheter patterns [PDF]
Purpose: To determine whether alternative high dose rate prostate brachytherapy catheter patterns can result in similar or improved dose distributions while providing better access and reducing trauma. Materials and Methods: Standard prostate cancer high dose rate brachytherapy uses a regular grid of parallel needle positions to guide the catheter ...
Pouliot, Jean +2 more
openaire +3 more sources
Perioperative high dose rate (HDR) brachytherapy in unresectable locally advanced pancreatic tumors
Purpose: The aim of the study was to present an original technique of catheter implantation for perioperative HDR-Ir192 brachytherapy in patients after palliative operations of unresectable locally advanced pancreatic tumors and to estimate the influence
Brygida Białas +5 more
doaj
Changing practice of Inpatient HDR brachytherapy in Carcinoma Cervix to an Outpatient procedure
Changing practice of Inpatient HDR brachytherapy in Carcinoma Cervix to an Outpatient ...
Aaron, Judith, Aaron, Judith (5276617)
core +1 more source
Applicator Attenuation Effect on Dose Calculations of Esophageal High-Dose Rate Brachytherapy Using EDR2 Film [PDF]
Introduction Interaluminal brachytherapy is one of the important methods of esophageal cancer treatment. The effect of applicator attenuation is not considered in dose calculation method released by AAPM-TG43. In this study, the effect of High-Dose Rate (
Seyed Mohsen Hosseini Daghigh +6 more
doaj +1 more source
ABSTRACT Background Platinum‐doublet concurrent chemoradiotherapy (CCRT) for locally advanced cervical cancer (LACC) is frequently complicated by severe neutropenia. This Phase II trial investigated whether combining active bone marrow‐sparing (ABMS) radiotherapy with prophylactic pegylated recombinant human granulocyte colony‐stimulating factor (PEG ...
ShanBing Wang +7 more
wiley +1 more source
Abstract Background Proton FLASH radiotherapy has demonstrated promising normal tissue sparing for similar tumor control at ultra‐high dose rates (> 40 Gy/s), but systematic investigation of dose‐rate‐dependent biological mechanisms is limited. Most existing proton platforms operate within a narrow dose‐rate range. Synchrotron‐based systems are further
Zongsheng Hu +4 more
wiley +1 more source
To compare the QoL of patients diagnosed with low- or favorable-intermediate-risk PCa after focal HDR brachytherapy and active surveillance. Our secondary objectives were to compare progression-free survival (PFS) between patients who underwent focal ...
Jonusas Justinas +8 more
doaj +1 more source
Trends in brachytherapy utilization in Canada from 2011 to 2020
Background and Purpose:: Brachytherapy is a highly conformal and cost-effective radiotherapy modality, yet its clinical utilization has declined in multiple regions.
Mirta Dumančić +15 more
doaj +1 more source
Dosimetric comparison of surface mould HDR brachytherapy with VMAT
Introduction The aim of this study was to investigate the dosimetric differences between surface mould high‐dose‐rate (HDR) brachytherapy and external beam volumetric‐modulated arc therapy (VMAT) for two treatment sites.
Eeva L. Boman +4 more
doaj +1 more source

